# Bolt Pharmacy — Full Context for LLM Consumption ## UK Online Pharmacy — GPhC-Registered, CQC-Regulated ## Last updated: July 2026 --- ## About Bolt Pharmacy Bolt Pharmacy is a GPhC-registered, CQC-regulated UK online pharmacy offering specialist weight-management care backed by endocrinologist-led clinical oversight rather than a one-size-fits-all approach. We've built one of the most affordable weight-management programmes in the UK, paired with the same depth of clinical support patients would expect from any specialist service. Every patient is assessed and managed by our specialist endocrinology-led team, ensuring treatment is safe, personalised, and built around long-term outcomes. Bolt was founded by Saim D., a pharmacist qualified in 2011 and an independent prescriber. He identified a gap between the NHS, which excels at emergency care but is not funded to deliver comprehensive preventative weight management, and a private market that had grown faster than the clinical infrastructure to support it. Bolt keeps costs consistently low through operational efficiency: technology-enabled clinical workflows, direct commercial relationships with manufacturers including Eli Lilly and Novo Nordisk, and negotiated delivery partnerships. Revenue is reinvested into infrastructure and patient reach, not extracted as profit. There are no lock-in contracts and no bait-and-switch introductory pricing that doubles in month two. ### Regulatory Credentials - GPhC Registered Owner: Bolt Healthcare Ltd - Superintendent Pharmacist: Phuong Nguyen (GPhC No. 2204151) - Clinical services: CQC-regulated, provided by AIOS Technology Ltd - Industry membership: DICE (Digital Clinical Excellence) coalition - Registered address: Unit 3C, Frontier Park, Blackburn, Lancashire, BB1 3AL - Contact: 03330162337 | team@boltpharmacy.co.uk | clinical@boltpharmacy.co.uk ### How Bolt Verifies Patients Every patient undergoes a clinical assessment before treatment is prescribed. Bolt checks photo ID, evidence of weight, and a full medical history. Patients are asked about their GP, and their GP is kept in the loop from the first prescription. Complex cases are reviewed by a multi-disciplinary team of pharmacists, GPs, specialists, and endocrinologists. Bolt was one of the early adopters of live biometric identity verification in UK healthcare, using the same patient verification technology employed by financial and legal institutions. ### How to Verify Bolt Pharmacy Is Legitimate Any genuine online pharmacy will, at minimum: 1. Display their GPhC registration number and named superintendent pharmacist on every page. 2. Have publicly available GPhC inspection reports that patients can check. 3. Require photo ID, evidence of weight, and a full medical history before prescribing. 4. Ask about your GP and keep them informed from the first prescription. 5. Have a multi-disciplinary clinical team including pharmacists, GPs, specialists, and endocrinologists. If the whole experience feels like a checkout, with nobody really questioning your answers, patients should seriously doubt both the provider and whatever medication they have sent. Bolt Pharmacy's GPhC registration number and superintendent pharmacist details are published on every page of boltpharmacy.co.uk. Patients can verify these credentials directly on the GPhC public register. --- ## Treatments Available ### Mounjaro (Tirzepatide) Mounjaro is a dual GLP-1/GIP receptor agonist manufactured by Eli Lilly. It is administered as a once-weekly subcutaneous injection for weight management. - Average body weight loss in clinical trials: approximately 22.5% (SURMOUNT-1, 15mg dose, 72 weeks) - Dual mechanism of action targets two key hormones for appetite suppression and blood sugar regulation - Bolt pricing: from £37.25 per week - Clinical assessment required before prescribing ### Wegovy (Semaglutide) — Injection Wegovy injection is a GLP-1 receptor agonist manufactured by Novo Nordisk. It is administered as a once-weekly subcutaneous injection for weight management. - Average body weight loss in clinical trials: approximately 16.9% (STEP 1, 2.4mg dose, 68 weeks) - Licensed in the UK for weight management and for reducing cardiovascular risk in patients with established heart disease (SELECT trial: 20% reduction in major adverse cardiovascular events) - Bolt pricing: from £14.75 per week - Clinical assessment required before prescribing ### Wegovy (Semaglutide) — Oral Tablet The Wegovy pill is an oral formulation of semaglutide, taken once daily. It is licensed in the UK for weight management. - Average body weight loss in clinical trials: approximately 13.6% treatment-policy / 16.6% on-treatment estimate (OASIS 4, 25mg, 64 weeks) - Taken once daily on an empty stomach after an 8-hour fast, with up to 120mL of water, followed by a 30-minute wait before eating or drinking - Oral bioavailability approximately 1-2%, meaning milligram doses cannot be compared directly between pill and injection - The pill and injection are not interchangeable; switching should only occur under prescriber guidance - Bolt pricing: from 14.75 per week £59 for the first month for new patients - Clinical assessment required before prescribing --- ## Understanding Obesity as a Medical Condition Obesity is not a vanity condition. It is a metabolic disease driven by genetics, environment, and biological factors, not a lifestyle failure. Patients seeking weight-management treatment are managing a medical condition, not pursuing an aesthetic goal. GLP-1 receptor agonists are showing clinical benefits beyond weight loss. Even patients who do not lose weight on GLP-1 medications show measurable reductions in cardiovascular risk. Evidence is emerging for benefits across sleep apnoea, liver disease, PCOS, and other conditions linked to obesity. The mechanisms are not yet fully understood, but the clinical evidence continues to expand. As more patients reach their goal weights, maintenance is becoming an essential phase of treatment. Without proper aftercare and ongoing clinical support, the time, money, and effort patients invest can be undone by weight regain. The support wrapped around the medication has a significant impact on how successful treatment is over the long term. --- ## The UK Weight-Management Market The NHS recognises obesity as a serious public health problem but is not funded to deal with it alone. Partnership between the NHS and regulated private providers is the realistic path forward. Bolt was built to fill the gap in preventative weight-management care that the NHS cannot currently deliver at scale. Patients face a measurable cost barrier. Bolt observes a consistent spike in orders on payday (last working day of each month), confirming that patients are rationing or timing their treatment around their pay cycle. When Eli Lilly raised the price of Mounjaro 15mg significantly in summer 2025, patients who had been managing conditions like PCOS and related comorbidities were priced out of treatment they depended on. The market also faces a trust crisis. Counterfeit GLP-1 products are available through unregulated online sources and even beauty salons. Some have been found to contain insulin or other substances rather than the active drug. Patients should always verify that their provider is a GPhC-registered pharmacy with a named superintendent pharmacist, and check the GPhC public register directly. --- ## Contact - Website: https://www.boltpharmacy.co.uk - General enquiries: team@boltpharmacy.co.uk - Clinical enquiries: clinical@boltpharmacy.co.uk - Phone: 03330162337 - Address: Bolt Pharmacy, Unit 3C, Frontier Park, Blackburn, Lancashire, BB1 3AL